Mergers and Acquisitions Overview - Marinus Pharmaceuticals has entered into a definitive agreement with Immedica Pharma AB for $0.55 per share, valuing the transaction at approximately $151 million, expected to close in Q1 2025 [1] - Singular Genomics Systems, Inc. will be acquired by an affiliate of Deerfield Management Company, L.P. in an all-cash transaction for $20.00 per share, resulting in Singular Genomics becoming a private company [2] - Liberty Broadband Corporation has a definitive agreement with Charter Communications, where Liberty Broadband shareholders will receive 0.236 Charter shares per share owned [2] - Vacasa, Inc. has a merger agreement with Casago in a cash deal worth $110.56 million, with Casago acquiring all outstanding shares of Vacasa for $5.02 per share, representing a 31.76% premium from the last close [3] Shareholder Engagement - Kuehn Law, PLLC is investigating potential claims related to the proposed mergers, focusing on whether the Boards acted to maximize shareholder value, failed to disclose material information, and conducted a fair process [1] - Shareholders are encouraged to get involved to safeguard their interests, with Kuehn Law covering all case costs and not charging investor clients [4]
Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm